aubagio | Aubagio: Uses, Dosage & Side Effects

Keyword	CPC	PCC	Volume	Score	Length of keyword
aubagio	0.85	0.1	2718	90	7

Keyword	CPC	PCC	Volume	Score
aubagio	0.65	0.5	4540	27
aubagio side effects	0.74	0.8	2320	14
aubagio generic	1.1	0.8	759	86
aubagio medication	0.69	0.6	379	15
aubagio ms	1.31	0.8	1120	75
aubagio copay card	0.51	0.8	4122	6
aubagio cost	0.73	0.7	8175	40
aubagio efficacy	1.28	0.2	4311	78
aubagio start form	0.5	0.3	8103	65
aubagio 14 mg	1.38	0.5	257	89
aubagio sanofi	0.74	0.5	9281	49
aubagio prescribing information	0.52	0.9	713	59
aubagio teriflunomide	1.61	0.1	849	77
aubagio storage	1.3	0.1	6276	28
aubagio package insert	1.14	0.9	6239	95
aubagio copay assistance	0.46	0.5	3707	19
aubagio ema	0.5	0.4	5001	21
aubagio smpc	1.27	0.7	5430	25
aubagio patient assistance program	1.81	0.4	8317	22
aubagio farmaco	0.55	1	3498	32
aubagio fda approval	0.15	1	6807	97
aubagio fachinformation	1.81	0.8	9285	8

Search Results related to aubagio on Search Engine

Aubagio: Uses, Dosage & Side Effects - Drugs.com
drugs.com

https://www.drugs.com/aubagio.html

WebAug 23, 2023 · Aubagio is used to treat relapsing forms of multiple sclerosis in adults (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease). Aubagio is not a cure for MS. Warnings. Do not use Aubagio if you are pregnant or may become pregnant.

DA: 94 PA: 60 MOZ Rank: 99

Aubagio | National MS Society
nationalmssociety.org

https://www.nationalmssociety.org/Treating-MS/Medications/Aubagio

WebDescription. Aubagio® (teriflunomide), a pyrimidine synthesis inhibitor, is an oral compound that inhibits the function of specific immune cells that have been implicated in MS. It is related to leflunomide, a drug used to treat rheumatoid arthritis. Aubagio can inhibit a key enzyme required by white blood cells (lymphocytes) – which in turn ...

DA: 71 PA: 30 MOZ Rank: 24

AUBAGIO® (teriflunomide) tablets, for oral use - Sanofi
sanofi.us

https://products.sanofi.us/Aubagio/aubagio.html

WebAUBAGIO ® is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BACK TO TOP. 2 DOSAGE AND ADMINISTRATION. The recommended dose of AUBAGIO is 7 mg or 14 mg orally once daily.

DA: 2 PA: 74 MOZ Rank: 48

Teriflunomide - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Teriflunomide

WebTeriflunomide, sold under the brand name Aubagio, is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010. 2-year results were positive.

DA: 47 PA: 29 MOZ Rank: 69

Aubagio: Side Effects, Cost, Uses, Dosage, and More - Healthline
healthline.com

https://www.healthline.com/health/drugs/aubagio

WebSep 2, 2021 · What is Aubagio? If you have multiple sclerosis (MS), your doctor may prescribe Aubagio for you. It’s a prescription drug that’s used to treat the following conditions in adults: clinically...

DA: 29 PA: 63 MOZ Rank: 15

Aubagio: 7 things you should know - Drugs.com
drugs.com

https://www.drugs.com/tips/aubagio-patient-tips

WebDec 28, 2022 · Aubagio is a brand (trade) name for teriflunomide and is used to treat relapsing forms of multiple sclerosis (MS) in adults. Experts aren't sure exactly how Aubagio works in MS, but it is thought to decrease inflammation by lowering the number of white blood cells (activated lymphocytes) in the central nervous system, which protects the …

DA: 92 PA: 36 MOZ Rank: 37

Aubagio Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
webmd.com

https://www.webmd.com/drugs/2/drug-162505/aubagio-oral/details

WebThis medication is used by adults to treat multiple sclerosis -MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells ( lymphocytes) which can attack the...

DA: 100 PA: 60 MOZ Rank: 60

Aubagio | European Medicines Agency
europa.eu

https://www.ema.europa.eu/en/medicines/human/EPAR/aubagio

WebMar 26, 2014 · Overview. Aubagio is a medicine that contains the active substance teriflunomide. It is used to treat patients from the age of 10 years with multiple sclerosis (MS), a disease in which inflammation destroys the protective sheath around the nerves.

DA: 40 PA: 90 MOZ Rank: 92

Aubagio (teriflunomide) | MultipleSclerosis.net
multiplesclerosis.net

https://multiplesclerosis.net/treatment/aubagio

Web4 min read. Reviewed by: HU Medical Review Board | Last reviewed: April 2023. Aubagio is an oral treatment approved to treat clinically isolated syndrome (CIS), relapsing-remitting MS, and active secondary progressive MS. Aubagio is a type of immunomodulatory drug, called a pyrimidine synthesis inhibitor. 1. What are the ingregients in Aubagio?

DA: 20 PA: 7 MOZ Rank: 12

Teriflunomide (Aubagio) | MS Society
mssociety.org.uk

https://www.mssociety.org.uk/about-ms/treatments-and-therapies/disease-modifying-therapies/teriflunomide

WebWho can take teriflunomide (Aubagio)? In Scotland, Wales and Northern Ireland you can take teriflunomide (its brand name is Aubagio) if: you have relapsing MS and you’ve had a recent relapse and/or if MRI scans show new signs that their MS is active (you have new lesions) In England you can have this drug if:

DA: 33 PA: 23 MOZ Rank: 51